Aurobindo Pharma Limited (AUROPHARMA.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In INR
| Market Cap | 757.64B |
| Enterprise Value | 739.67B |
| P/E Ratio | 26.5 |
| PEG Ratio | 1.56 |
| Price/Sales Ratio | 2.85 |
| Price/Book Ratio | 2.67 |
| Enterprise/Revenue | 2.82 |
| Enterprise/EBITDA | 12.94 |
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | 0.11 |
| Operating Margin | 0.15 |
| Return On Assets | 0.06 |
| Return On Equity | 0.11 |
| Revenue | 336.53B |
| Revenue/Share | 640.74 |
| Gross Profit | 131.96B |
| EBITDA | 72.74B |
| Net Income | 35.05B |
| Diluted EPS | 60.34 |
| Total Cash | 99.78B |
| Total Cash/Share | 173.41 |
| Total Debt | 86.3B |
| Total Debt/Equity | 0.22 |
| Current Ratio | 1.73 |
| Book Value Per Share | 684.71 |
| 52-Week Change | 56.44 |
| 52-Week High | 1,859.9 |
| 52-Week Low | 1,106 |
| Moving Average 50 Days | 1,681.01 |
| Moving Average 200 Days | 1,493.22 |
| Average Volume | 909,199 |
| Shares Outstanding | 575.38M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 7 |
| Trailing Annual Dividend Yield | 0.38 |
| Payout Ratio | 0.06 |
| Last Split Factor | 2:1 |
| Last Split Date | July 20, 2015 |